Series B · BiotechMediar Therapeutics: Series BDevelops therapies to halt fibrosis in multiple organ systemsPublished Oct 4, 2026By RoundOS Funding deskFunding historyJan 7, 2026Series B · This round$76MSourcesprnewswire.com↗
MetriportOpen-source healthcare data infrastructure unifying patient records for clinicians$26MSeries A · Aug 27, 2026
AusperBioDevelops oligonucleotide therapeutics targeting chronic hepatitis B$120MSeries C · Aug 27, 2026
ProFound TherapeuticsUses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia$35MStrategic · Aug 27, 2026
ArintraAI platform automating medical coding and revenue assurance for health systems$25MSeries B · Aug 26, 2026